Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Recombinant urate oxidase injection in hyperuricemia after chemoradiotherapy
CTR20132897Phase 2Suspended
- Sponsor
- Hangzhou Beidou Biotechnology
- Start
- Apr 2014
- Modality
- Replacement Enzymes → Therapeutic Enzymes → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of rasburicase in hyperuricemia, sponsored by Hangzhou Beidou Biotechnology. Started Apr 2014; status: suspended.
02
Drugs
rasburicase
03
Conditions
hyperuricemia
Beyond the preview
Go deeper on CTR20132897.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20132897.